- (1) Beginning in 2023, the state department shall, in collaboration with the administrator of the all-payer health claims database described in section 25.5-1-204, conduct an annual analysis of the prescription drug rebates received in the previous calendar year, by health insurance carrier and prescription drug tier. The analysis, using data from the all-payer health claims database and other sources, must be completed on or before May 1 of each year.
- (2) The state department shall make the analysis conducted in subsection (1) of this section available to the public on an annual basis.
Source: L. 2022: Entire section added, (HB 22-1370), ch. 184, p. 1237, § 7, effective August 10.